Range wide analysis of genetic diversity and structure gives insights into Rosa gallica L. evolutionary history

Pawula, C.; Clotault, J.; Lepais, O.; Chastellier, A.; Ordonez Trejo, E. J.; Thouroude, T.; Assini, S.; Bakay, L.; Bartha, L.; Bavcon, J.; Cambecedes, J.; Cordier, J.; Cwener, A.; Dajdok, Z.; Drevojan, P.; Garcia, J.; Grahic, J.; Kapler, A.; Kerenyi-Nagy, V.; Konjic, A.; Łazarski, G.; Leblond, N.; Mrkvicka, A.; Nepras, K.; Oliiar, H.; Pascale, M.; Pejic, I.; Piwowarczyk, R.; Ravnjak, B.; Salvesen, P. H.; Sarateanu, V.; Schanzer, I.; Soldano, A.; Tofan-Dorofeev, E.; Tomljenovic, N.; Wisniewska, K.; Wolanin, M.; Malecot, V.; Grapin, A.; Pernet, A.

doi:10.64898/2026.08.05.742742

Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.08.05.742742

Range wide analysis of genetic diversity and structure gives insights into Rosa gallica L. evolutionary history

View original source ↗Export metadata ↓

Abstract

Rosa gallica L., the French rose, is a perennial, tetraploid, heterozygous species that naturally propagates by seed and sucker. It occurs in the wild, primarily in Europe, and also exists as cultivated varieties. R. gallica cultivars were extensively bred and cultivated in France at the beginning of the 19th century. Although several hypotheses have been proposed regarding the species expansion based on historical records, none have been assessed using molecular data. Indeed, its genetic diversity has so far been investigated only at local or regional scales, hindering the identification of the evolutionary factors shaping its present-day distribution. Using 29 sequenced microsatellites, we genotyped a comprehensive sample of 1618 individuals, including wild R. gallica from 219 sites across the species range, rose cultivars, and specimens from other Rosa species. We then detected clonal lineages and characterized the range-wide genetic diversity and structure, aiming to disentangle the roles of natural and human factors in shaping the distribution of R. gallica, with particular focus on France. French diversity appears particularly structured compared to the rest of the range, suggesting multiple origins within France. Populations in South Alps, Central Eastern Europe, and Eastern France appear to have recolonized naturally from a single southern glacial refugium. In contrast, populations in the western part of France likely resulted from more recent natural or human-mediated dispersal. Finally, clonal lineages containing both wild and cultivated individuals were predominantly found in France, highlighting the role of human-mediated dispersal in 28 of the 98 French sites studied. These findings show that the present-day natural range of R. gallica was shaped primarily by post-glacial recolonization, but also reveal a contribution of human activities to its recent dispersal, particularly in France, where cultivated varieties were intensively bred and exchanged.

Explore related subjects

genetics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Pawula, C., Clotault, J., Lepais, O., Chastellier, A., Ordonez Trejo, E. J., Thouroude, T., Assini, S., Bakay, L., Bartha, L., Bavcon, J., Cambecedes, J., Cordier, J., Cwener, A., Dajdok, Z., Drevojan, P., Garcia, J., Grahic, J., Kapler, A., Kerenyi-Nagy, V., Konjic, A., Łazarski, G., Leblond, N., Mrkvicka, A., Nepras, K., Oliiar, H., Pascale, M., Pejic, I., Piwowarczyk, R., Ravnjak, B., Salvesen, P. H., Sarateanu, V., Schanzer, I., Soldano, A., Tofan-Dorofeev, E., Tomljenovic, N., Wisniewska, K., Wolanin, M., Malecot, V., Grapin, A., Pernet, A.. 2026-08-11. Range wide analysis of genetic diversity and structure gives insights into Rosa gallica L. evolutionary history. https://doi.org/10.64898/2026.08.05.742742

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗